SCHEMBL10183929

SCHEMBL10183929

Cn1ccc(N(C(=O)CN2CCCc3ccccc32)C2C(=O)N(C3CCCCC3)c3ccccc32)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 9/20 0.43
▸ CHRM4 P08173 9/20 0.43
▸ CHRM1 P11229 9/20 0.43
▸ CHRM3 P20309 9/20 0.43
▸ ALDH1A1 P00352 4/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ OPRM1 P35372 3/20 0.39
▸ OPRK1 P41145 3/20 0.39
▸ OPRL1 P41146 3/20 0.39
▸ MEN1 O00255 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ CASP7 P55210 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ GAA P10253 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10185675 0.85 ALDH1A1 (0.41) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL10184173 0.82 OPRM1 (0.37) KDM4EOPRM1OPRK1OPRL1KMT2A
SCHEMBL10183302 0.80 PTAFR (0.41) ALDH1A1OPRM1OPRK1OPRL1MAPT
SCHEMBL10185657 0.80 IDH1 (0.47) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL10183670 0.79 TRPM8 (0.41) OPRM1OPRK1OPRL1GAA
SCHEMBL10183722 0.77 TP53 (0.41) ALDH1A1KDM4EOPRM1OPRK1OPRL1
SCHEMBL10183271 0.76 MAPT (0.42) ALDH1A1OPRM1OPRK1OPRL1MEN1
SCHEMBL10183233 0.75 CHRM2 (0.44) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL10184168 0.72 OPRM1 (0.37) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL15119064 0.69 IDH1 (0.65) CHRM2CHRM4CHRM1CHRM3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback